We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Technology Developed for Mapping Blood Vessels May Aid Cancer Research

By LabMedica International staff writers
Posted on 08 Dec 2011
Similar to healthy tissue, tumors flourish on nutrients carried to them by the blood stream. More...
The fast growth of new blood vessels is a key characteristic of cancer, and new research has demonstrated that suppressing blood vessel growth can also keep tumors from growing. To determine better the relationship between cancer and the vascular system, scientists are making detailed maps of the entire network of blood vessels in organs.

Regrettably, the current mapping process is time-consuming: using traditional methods, mapping a 1-cm block of tissue can take months. In a paper published in the October 2011 issue of the Optical Society’s (OSA) open-access journal Biomedical Optics Express, computational neuroscientists from Texas A&M University (College Station, USA), along with collaborators at the University of Illinois (Urbana-Champaign, USA) and Kettering University (Flint, MI, USA), described a new system, evaluated in mouse brain samples, that considerably reduces that time.

The technology employs a technique called knife-edge scanning microscopy (KESM). First, blood vessels are filled with ink, and the whole brain sample is embedded in plastic. Next, the plastic block is placed onto an automated vertically moving stage. A diamond knife shaves a very thin slice -one micrometer or less--off the top of the block, imaging the sample line by line at the tip of the knife. Each tiny movement of the stage triggers the camera to take a picture. In this way, the researchers can get the full 3D structure of the mouse brain’s vascular network--from arteries and veins down to the smallest capillaries--in less than two days at full production speed. In the future, the investigators plan to augment the process with fluorescence imaging, which will allow researchers to tie brain structure to function.

Related Links:
Texas A&M University
University of Illinois
Kettering University



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Automated Clinical Chemistry Analyzer
Envoy 500+
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers identified 157 metabolites linked to BBB damage, including 25 that appeared in at least two independent studies (Image Credit: Adobe Stock)

Blood Metabolite Patterns May Enable Early Detection of Blood-Brain Barrier Injury

Early injury to the blood-brain barrier (BBB) can precede many neurological disorders but remains difficult to detect noninvasively. Laboratory markers that identify barrier dysfunction before symptoms... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.